Groups that represent 340B hospitals praised the Biden administration’s decision Friday to end a deep cut in the hospitals’ Medicare Part B drug reimbursement in place since 2018. They urged the government to swiftly make 340B hospitals whole for their losses, which totaled an estimated $1.6 billion a year for five years.
Private oncology practices that compete with 340B hospitals called the Centers for Medicare and Medicaid Services’ (CMS) hospital outpatient prospective payment system (OPPS) proposed rule for 2023 and its decision to end the payment cut for 340B hospitals “an outrageous dereliction of duty by an agency responsible for the financial health of the country’s Medicare program.”
Groups that represent 340B hospitals praised the Biden administration’s decision Friday to end a deep cut in the hospitals’ Medicare Part B drug reimbursement in place since 2018. They urged the government to swiftly make 340B hospitals whole for their losses, which totaled an estimated $1.6 billion a year for five years.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
